Pipeline
Overview
Silenseed is utilizing its proprietary LODER platform to enable treatment of cancers triggered by previously “undruggable” proteins. The LODER Platform, with its local and continuous drug delivery properties, provides a safe and effective strategy that can be applied to the treatment of different types of solid tumors.